| HOME >> BIOLOGY >> TECHNOLOGY |
Deferred income 5,210,120 4,895,049
Total non current liabilities 8,985,629 9,700,921
Total liabilities 42,012,449 42,445,681
MINORITY INTEREST 8,484,637 6,144,063
SHAREHOLDERS' EQUITY:
Common stock, $0.001 par value,
250,000,000 shares authorized,
71,333,586 issued and outstanding,
respectively 71,334 71,334
Paid-in-capital 8,842,009 8,842,009
Statutory reserves 9,420,783 9,420,783
Retained earnings 86,918,663 78,668,160
Accumulated other comprehensive income 23,059,672 15,960,044
Total shareholders' equity 128,312,461 112,962,330
Total liabilities and
shareholders' equity $ 178,809,547 $ 161,552,074
TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2008 AND 2007 (UNAUDITED)
June 30, June 30,
2008 2007
As Adjusted
(Note 1)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income $ 8,250,503 $ 11,512,659
Adjustments to reconcile net income
to cash provided by (used in)
operating activities:
Provision for doubtful accounts 37,715 547
Minority interest 1,887,079 3,122,579
Depreciation
'/>"/>
| SOURCE Tiens Biotech Group (USA), Inc. Copyright©2008 PR Newswire. All rights reserved |